Computerized bone scan. A potentially useful technique to measure response in prostatic carcinoma

Area of Science:

• Oncology
• Nuclear Medicine
• Radiology

Background:

• Prostate cancer frequently metastasizes to bone, necessitating reliable methods to monitor treatment efficacy.
• Assessing treatment response in metastatic bone disease is crucial for patient management and prognosis.

Purpose of the Study:

• To evaluate the utility of Computerized Bone Scanning (CBS) for objectively measuring treatment response in patients with prostate cancer bone metastases.
• To correlate CBS findings with objective response criteria and clinical outcomes.

Main Methods:

• Sequential Computerized Bone Scanning (CBS) was performed on ten patients with histologically confirmed prostate cancer metastatic to bone.
• Quantitative changes in bone scan uptake were analyzed and correlated with objective response criteria and clinical parameters.

Main Results:

• A significant decrease in CBS counts (>50%) correlated well with objective treatment responses and improved pain control.
• Worsening disease by CBS parameters aligned with other indicators of progression, including new bone lesions and poor survival.
• Changes in CBS uptake were observed within the first month of therapy, with stabilization noted by three months.

Conclusions:

• Computerized Bone Scanning (CBS) provides a quantitative and objective method for evaluating treatment response in prostate cancer with bone metastases.
• CBS is a potentially valuable tool for monitoring therapeutic efficacy and guiding clinical decisions in this patient population.